Kelun Lifesciences (Pvt) Ltd

Kelun is a highly specialized innovative pharmaceutical group with annual sales revenue over 40 billion RMB, including more than 100 enterprises at home and abroad, Sichuan Kelun Pharmaceutical Co., Ltd; Sichuan Kelun Drug Research Institute Co., Ltd; Klus Pharma Inc. (Kelun, USA), Kelun KAZ Pharmaceutical Co., Ltd (Kelun, Kazakhstan); Sichuan Kelun Medicine Trade Co., Ltd, etc. In 2017, kelun ranked 155th in Chinas top 500 manufacturing enterprises, and comprehensive strength ranked top three in Chinas pharmaceutical industry. Sichuan Kelun Pharmaceutical Co., ltd. was listed on the Shenzhen Stock Exchange in June 2010. At the same time, Kelun immediately launched the plan of 10 billion RMB industrial investment and began to implement the development strategy of three development driving engines and innovative growth.The first engine is through continuous industrial upgrading and product variety adjustment, to maintain Keluns absolute leading position in the field of IV infusion; ...